Egis Egiramlon medication

Egiramlon is a pharmaceutical product used for the treatment of hypertension (high blood pressure). It consists of a fixed-dose combination of Ramipril, an ACE inhibitor, and Amlodipine, a calcium channel blocker. The product is manufactured and marketed by Egis Pharmaceuticals PLC, a leading pharmaceutical company in Central and Eastern Europe.

Egis Pharmaceuticals was founded in Hungary in 1913 and has grown into a major regional player in the healthcare industry. While it has its roots in Budapest, the company is currently a major subsidiary of the Servier Group, an international pharmaceutical company based in France. Egiramlon is typically produced in Egis's manufacturing facilities in Hungary, following strict European pharmaceutical standards. This medication is primarily distributed across the European and CIS markets where Egis maintains a strong commercial presence.